Related Experiment Video
Updated: Jan 7, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.8K
Traumatic brain injury-related ferroptosis: current perspectives
Rongkun Zhu1, Jizhou Pan2, Yucong Min2
1Department of Neurosurgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China.
Summary
Traumatic brain injury (TBI) triggers ferroptosis, a cell death pathway involving iron and lipid peroxidation. Targeting ferroptosis shows promise for TBI treatment by reducing neuronal damage.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Traumatic brain injury (TBI) is a major cause of death and disability.
- Secondary injury mechanisms, including ferroptosis, worsen neuronal damage after TBI.
- Ferroptosis is an iron-dependent cell death characterized by lipid peroxidation.
Purpose of the Study:
- To review current evidence on ferroptosis in TBI.
- To highlight ferroptosis pathways and their intersection with other cellular processes.
- To discuss therapeutic strategies targeting ferroptosis for TBI.
Main Methods:
- Literature review synthesizing current evidence on ferroptosis in TBI.
- Analysis of ferroptosis core pathways: iron metabolism, lipid peroxidation, and glutathione depletion.
- Examination of TBI-associated ferroptosis markers and therapeutic interventions.
Main Results:
- Ferroptosis involves iron dysregulation, lipid peroxidation (ACSL4/LPCAT3), and glutathione depletion (System Xc-/GSH/GPX4).
- Ferroptosis exacerbates neuronal death by interacting with mitochondrial dysfunction, ER stress, and neuroinflammation.
- The hippocampus shows increased ferroptosis markers post-TBI; various agents demonstrate neuroprotection.
Conclusions:
- Targeting ferroptosis pathways offers a potential therapeutic strategy for TBI.
- Further research is needed to address gaps in understanding ferroptosis crosstalk and clinical translation.
- Optimizing drug delivery and validating biomarkers are crucial for clinical application.

